Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2047939
Max Phase: Preclinical
Molecular Formula: C12H12Cl2O3
Molecular Weight: 275.13
Molecule Type: Small molecule
Associated Items:
ID: ALA2047939
Max Phase: Preclinical
Molecular Formula: C12H12Cl2O3
Molecular Weight: 275.13
Molecule Type: Small molecule
Associated Items:
Synonyms (1): Ethyl 2-((2,4-Dichlorophenyl)(Hydroxy)Methyl)Acrylate
Synonyms from Alternative Forms(1):
Canonical SMILES: C=C(C(=O)OCC)C(O)c1ccc(Cl)cc1Cl
Standard InChI: InChI=1S/C12H12Cl2O3/c1-3-17-12(16)7(2)11(15)9-5-4-8(13)6-10(9)14/h4-6,11,15H,2-3H2,1H3
Standard InChI Key: VCOVRIRJUVQYAG-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 275.13 | Molecular Weight (Monoisotopic): 274.0163 | AlogP: 3.15 | #Rotatable Bonds: 4 |
Polar Surface Area: 46.53 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 13.37 | CX Basic pKa: | CX LogP: 3.38 | CX LogD: 3.38 |
Aromatic Rings: 1 | Heavy Atoms: 17 | QED Weighted: 0.68 | Np Likeness Score: -0.21 |
1. Lima-Junior CG, Vasconcellos ML.. (2012) Morita-Baylis-Hillman adducts: biological activities and potentialities to the discovery of new cheaper drugs., 20 (13): [PMID:22632793] [10.1016/j.bmc.2012.04.061] |
2. Cocco M, Garella D, Di Stilo A, Borretto E, Stevanato L, Giorgis M, Marini E, Fantozzi R, Miglio G, Bertinaria M.. (2014) Electrophilic warhead-based design of compounds preventing NLRP3 inflammasome-dependent pyroptosis., 57 (24): [PMID:25418070] [10.1021/jm501072b] |
3. Cocco M, Pellegrini C, Martínez-Banaclocha H, Giorgis M, Marini E, Costale A, Miglio G, Fornai M, Antonioli L, López-Castejón G, Tapia-Abellán A, Angosto D, Hafner-Bratkovič I, Regazzoni L, Blandizzi C, Pelegrín P, Bertinaria M.. (2017) Development of an Acrylate Derivative Targeting the NLRP3 Inflammasome for the Treatment of Inflammatory Bowel Disease., 60 (9): [PMID:28410442] [10.1021/acs.jmedchem.6b01624] |
Source(1):